Related Experiment Video

Updated: Jun 11, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants
09:18

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Published on: December 20, 2011

Pain management in the paediatric population: the regulatory situation in Europe

F Fortinguerra1, S Maschi, A Clavenna

  • 1Department of Public Health, Mario Negri Institute for Pharmacological Research, Milan, Italy. filomena.fortinguerra@marionegri.it

Archives of Disease in Childhood
|June 30, 2010
PubMed

Insights

Availability of pediatric pain relief drugs varies across Europe, with significant differences in licensing and age indications. Further research is needed to improve pain management in children.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Pain Management

Background:

  • Analgesic drug availability and licensing for pediatric use present challenges.
  • The European Medicines Evaluation (EMA) document "Assessment of Pediatric Needs: Pain" (2005) identified key drugs for pain management in children.

Purpose of the Study:

  • To compare the availability and licensing status of analgesic drugs in Italy, France, and the UK.
  • To evaluate the evidence on the safety and efficacy of these drugs in pediatric populations.

Main Methods:

  • A review of analgesic drugs listed in the EMA document was conducted.
  • Licensing status and age group indications were compared across three European countries.
  • Biomedical literature databases were searched for randomized controlled trials (RCTs).

Main Results:

  • Ten of 17 EMA-listed drugs had pediatric licenses in all three countries, but with significant variations in age indications.
  • A total of 594 RCTs were identified for the 17 drugs.
  • Bupivacaine had the most RCTs (171), while clonidine (32 RCTs) and ketamine (51 RCTs) showed specific licensing limitations.

Conclusions:

  • Significant disparities exist in pediatric analgesic drug licensing and availability across European countries.
  • There is a critical need for enhanced research and clinical development in pediatric pain assessment and management.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...